
Pathways Bioscience PB125 Enhances Vascular Function in Older Adults
Edited by Vita Solenne
Research & Biotech · Updated October 2, 2026
A recent study published in Free Radical Biology and Medicine has shown that PB125, a supplement developed by Pathways Bioscience, significantly improves vascular endothelial function in older adults. The randomized, double-blind, placebo-controlled trial involved 24 older adults and demonstrated a 65% increase in brachial artery flow-mediated dilation after just two weeks of supplementation. These findings suggest potential benefits for cardiovascular health in the aging population.
Share this story
Why it matters
- ✓Improved vascular function can lead to better overall cardiovascular health, which is crucial for longevity.
- ✓Enhancing endothelial function may reduce the risk of age-related diseases, making PB125 a potential tool for health optimization.
- ✓The study's results could encourage further research into supplements that support vascular health in older adults.
Pathways Bioscience PB125 Enhances Vascular Function in Older Adults
Introduction
Pathways Bioscience has recently published promising results from a randomized, double-blind, placebo-controlled study evaluating the effects of their supplement PB125 on vascular function in older adults. The study, which appeared in the journal Free Radical Biology and Medicine, involved both younger and older adults, with a focus on how PB125 supplementation could improve endothelial function, a critical aspect of cardiovascular health.
Study Overview
The clinical trial included 20 younger adults and 24 older adults, allowing researchers to compare the effects of PB125 across different age groups. The primary outcome measured was flow-mediated dilation (FMD) of the brachial and popliteal arteries, which serves as a key indicator of endothelial function.
After just two weeks of PB125 supplementation, the results were significant, particularly for the older participants. The brachial artery flow-mediated dilation increased by approximately 65%, indicating a substantial improvement in vascular endothelial function. This enhancement is particularly noteworthy, as endothelial dysfunction is a common issue in older adults and is associated with various cardiovascular diseases.
Implications for Vascular Health
The findings from this study suggest that PB125 may play a role in improving vascular health among older adults. Endothelial function is crucial for maintaining vascular tone and blood flow, and its decline is often linked to aging and the onset of cardiovascular conditions. By improving endothelial function, PB125 could potentially help mitigate some of the risks associated with aging, including hypertension and atherosclerosis.
Importance of Vascular Function
Vascular health is a cornerstone of overall health and longevity. As individuals age, maintaining good endothelial function becomes increasingly important. Poor vascular function can lead to various health issues, including heart disease, stroke, and other age-related conditions. Therefore, supplements like PB125 that show promise in enhancing vascular function could be valuable tools for those pursuing longevity and health optimization.
Conclusion
The results of the Pathways Bioscience study on PB125 highlight the potential of this supplement to improve vascular function in older adults. With a significant increase in brachial artery flow-mediated dilation observed after just two weeks of supplementation, PB125 may offer a new avenue for enhancing cardiovascular health in the aging population. As research continues to evolve, further studies will be essential to confirm these findings and explore the long-term benefits of PB125 for longevity enthusiasts and health optimizers alike.
In summary, while the current study provides a solid foundation for the potential benefits of PB125, additional research will be necessary to fully understand its implications and effectiveness in broader populations.
Sources
- Pathways Bioscience PB125 improves vascular function in older adults — Longevity Technology
Newsletter
Your weekly longevity signal. No spam.
Comments
Log in with
Loading comments…
More in Biotech

Exploring the Connection Between Big Pharma and Gray-Market Peptides
A recent analysis reveals significant ties between the pharmaceutical industry and gray-market…
2d ago

Kailera Completes Enrollment for Obesity Trials, Results Expected in 2028
Kailera has completed enrollment for its three Phase 3 trials of ribupatide, a weekly injection…
2d ago

Longeveron’s Stem Cell Therapy Shows Promise for Reducing Brain Inflammation in Alzheimer’s Patients
Longeveron has released new preclinical data suggesting that its stem cell therapy may lead to…
2d ago

Heart Pill Reduces Inflammation Markers in Initial Study
Monte Rosa's NEK7-targeting drug has shown promise in reducing several heart-risk biomarkers in a…
2d ago